| Lundbeck reorganises European operations |
PMLiVEPrior to joining Lundbeck he served with Merck and Schering-Plough and in his new role will have responsibility for Lundbeck's commercial activities in the majority of Western European countries. Meanwhile Quingueran-Beajeuwill joins Lundbeck from ...
|
| Attorney General recovers $2.5 million from drug companies |
BayoubuzzThe companies—Actavis, Boehringer Ingelheim, Dey, GlaxoSmithKline, and Schering-Plough—have agreed to pay Louisiana a combined total of $25.2 million for misreporting drug price information in order to improperly increase reimbursements paid by ...
|
| Beads & Boos: Louisiana AG brings the right fight to fraud |
Alexandria Town TalkThe companies -- Actavis, Boehringer Ingelheim, Dey, GlaxoSmithKline, and Schering-Plough -- have agreed to pay Louisiana a combined total of $25.2 million for misreporting drug price information. "These settlement funds are just the tip of the iceberg ...
|
| La. AG hauls in $25.2M from five drug companies |
Legal News LineSchering-Plough, GlaxoSmithKline, Dey, Boehringer Ingelheim and Actavis agreed to pay the state a combined total of $25.2 million to resolve allegations of misreporting drug price information to increase reimbursements paid by the taxpayer-funded ...
|
| Drug Makers To Pay $25.2M To Settle Fraud Claims |
Manufacturing.netActavis, Boehringer Ingelheim, Dey, GlaxoSmithKline and Schering-Plough are the companies involved in Tuesday's settlement announcement. A Caldwell spokeswoman says the state health department will receive more than $20 million from the settlement and ...
|
| Drug makers to pay $25.2M to settle fraud claims |
BusinessWeekActavis, Boehringer Ingelheim, Dey, GlaxoSmithKline and Schering-Plough are the companies involved in Tuesday's settlement announcement. A Caldwell spokeswoman says the state health department will receive more than $20 million from the settlement and ...
|
| Louisiana AG Recovers $25.2M from Drug Companies Charged with Fraud |
Insurance JournalThe companies — Actavis, Boehringer Ingelheim, Dey, GlaxoSmithKline, and Schering-Plough — have agreed to pay Louisiana a combined total of $25.2 million for misreporting drug price information in order to improperly increase reimbursements paid by ...
|
